Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ARCT - Why Arcturus Therapeutics Has A Promising Future With Innovative CF And COVID Treatments

ARCT - Why Arcturus Therapeutics Has A Promising Future With Innovative CF And COVID Treatments

Arcturus Therapeutics Ltd.

2024-02-02 11:25:32 ET

Summary

  • Arcturus Therapeutics is a biotechnology company specializing in rare and infectious diseases, with approved COVID and influenza vaccines in Japan and the EU.
  • The company is developing game-changing therapies for Ornithine Transcarbamylase Deficiency and Cystic Fibrosis.
  • Despite trading at a slight premium relative to peers, ARCT's investment appeal is supported by its innovative IP, financial health, and clinical trials.
  • Arcturus has promising partnerships with CSL, Meiji, and Arcalis for vaccine development, and its solid financial footing makes it a "buy" at current levels.

...

For further details see:

Why Arcturus Therapeutics Has A Promising Future With Innovative CF And COVID Treatments
Stock Information
Company Name: Arcturus Therapeutics Ltd.
Stock Symbol: ARCT
Market: NASDAQ
Website: arcturusrx.com
Menu
ARCT ARCT Quote ARCT Short ARCT News ARCT Articles ARCT Message Board
Get ARCT Alerts

News, Short Squeeze, Breakout and More Instantly...